JPL Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$64.5K Sell
1,119
-842
-43% -$48.3K 0.01% 226
2026
Q1
$119K Buy
+1,961
New +$114K 0.03% 149
2025
Q4
– Sell
-793
Closed -$35.8K – 248
2025
Q3
$35.8K Buy
+793
New +$37K 0.01% 290

Other funds holding BMY

JPL Wealth Management's BMY Position: Q2 2026 in Review

JPL Wealth Management reduced its Bristol-Myers Squibb (BMY) stake by 43% in Q2 2026, selling an estimated $48.3K and leaving 1,119 shares worth $64.5K. The position accounts for 0.01% of the portfolio, ranked #226.

JPL Wealth Management first reported a position in BMY in Q3 2025 and has held it in 3 quarters since. The position peaked at $119K in Q1 2026. 2,529 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • JPL Wealth Management held 1,119 shares of Bristol-Myers Squibb worth $64.5K as of Q2 2026.
  • JPL Wealth Management sold 842 Bristol-Myers Squibb shares in Q2 2026, an estimated $48.3K.
  • Bristol-Myers Squibb made up 0.01% of JPL Wealth Management's portfolio in Q2 2026, its #226 holding.
  • JPL Wealth Management first reported a position in Bristol-Myers Squibb in Q3 2025 and has held it in 3 quarters since.
  • JPL Wealth Management's Bristol-Myers Squibb position peaked at $119K in Q1 2026.
  • 2,529 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on JPL Wealth Management's 13F filing for Q2 2026, filed 14 Aug 2026.